| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cabozantinib S-malate | FAERS: 3 | US FAERS | |
| 2 | Sorafenib | FAERS: 3 | US FAERS | |
| 3 | regorafenib | FAERS: 2 | US FAERS | |
| 4 | Clarithromycin | FAERS: 1 | US FAERS | |
| 5 | Dipyrone | FAERS: 1 | US FAERS | |
| 6 | Ethylene Glycol | FAERS: 1 | US FAERS | |
| 7 | Febuxostat | FAERS: 1 | US FAERS | |
| 8 | Loperamide | FAERS: 1 | US FAERS | |
| 9 | Sunitinib | FAERS: 1 | US FAERS | |
| 10 | rofecoxib | FAERS: 1 | US FAERS | |
| 11 | Amoxicillin | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Daunorubicin | OFFSIDES | ||
| 13 | Diane | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Estrogens, Conjugated (USP) | OFFSIDES | ||
| 15 | Etodolac | OFFSIDES | ||
| 16 | cefpodoxime proxetil | OFFSIDES | ||
| 17 | cefpodoxime | OFFSIDES | ||
| 18 | distigmine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.